Novartis AG Interest Received Classified As Operating Activities
Novartis AG (NVSEF) reported Interest Received Classified As Operating Activities of $310.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:InterestReceivedClassifiedAsOperatingActivities · last filed 2026-02-04
- Novartis AG interest received classified as operating activities for the quarter ending 2025-06-30 was $39.00M, a 45.07% decline year-over-year.
- Novartis AG interest received classified as operating activities for the quarter ending 2024-06-30 was $71.00M, a 39.32% decline year-over-year.
- Novartis AG interest received classified as operating activities for the quarter ending 2023-06-30 was $117.00M, a 457.14% increase year-over-year.
- Novartis AG interest received classified as operating activities for the quarter ending 2022-06-30 was $21.00M, a 950.00% increase year-over-year.
| Period end | Interest Received Classified As Operating Activities 3 month | Interest Received Classified As Operating Activities 3 month as first filed | Interest Received Classified As Operating Activities 6 month | Interest Received Classified As Operating Activities 6 month as first filed | Interest Received Classified As Operating Activities 12 month | Interest Received Classified As Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $310.00M 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $39.00M 6-K · filed 2025-07-17 | $161.00M 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $489.00M 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $71.00M 6-K · filed 2025-07-17 | $235.00M 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $645.00M 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $117.00M 6-K · filed 2024-07-18 | $118.00M 6-K · filed 2023-07-18 | $373.00M 6-K · filed 2024-07-18 | $374.00M 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $252.00M 20-F · filed 2025-01-31 | $254.00M 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $21.00M 6-K · filed 2023-07-18 | $38.00M 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $11.00M 20-F · filed 2024-01-31 | $13.00M 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $2.00M 6-K · filed 2022-07-19 | $6.00M 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $47.00M 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $5.00M 6-K · filed 2021-07-21 | $37.00M 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $214.00M 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $55.00M 6-K · filed 2020-07-21 | $140.00M 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $241.00M 20-F · filed 2021-01-26 | $243.00M 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $36.00M 6-K · filed 2019-07-18 | $38.00M 6-K · filed 2018-07-18 | $86.00M 6-K · filed 2019-07-18 | $88.00M 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $97.00M 20-F · filed 2020-01-29 | |||||
| 2017-06-30 | $24.00M 6-K · filed 2018-07-18 | $42.00M 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $43.00M 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $34.00M 6-K · filed 2018-01-24 |